Finance

Lists
Q2 2027 earnings • released • EPS beat +9.78% • Revenue beat +2.24%
See results
NH:NSE
Narayana Hrudayalaya Ltd
₹1,928.00
+3.07%
(+57.40) 1D
Nov 4, 3:30:01 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for NH...
Open
₹1,886.70
High
₹1,935.50
Low
₹1,880.00
Mkt. cap
391.15B
Avg. vol.
188.15K
Volume
214.34K
Dividend
0.23%
Quarterly dividend
₹1.13
Ex-dividend date
Jul 17, 2026
P/E ratio
45.56
52-wk high
₹2,093.30
52-wk low
₹1,589.00
EPS
₹42.32
Shares outstanding
204.36M
No. of employees
11K
Open
₹1,886.70
High
₹1,935.50
Low
₹1,880.00
Mkt. cap
391.15B
Avg. vol.
188.15K
Volume
214.34K
Dividend
0.23%
Quarterly dividend
₹1.13
Ex-dividend date
Jul 17, 2026
P/E ratio
45.56
52-wk high
₹2,093.30
52-wk low
₹1,589.00
EPS
₹42.32
Shares outstanding
204.36M
No. of employees
11K
News stories
From web sources and news partners
Profile
Narayana Health is an Indian for-profit private hospital network headquartered in Bangalore. It was founded by Dr. Devi Shetty in the year 2000. It operates several hospitals and heart centres across major Indian cities Bangalore, Delhi, Gurugram, Kolkata, Ahmedabad, Raipur, Jaipur, Mumbai, Mysore etc. with an international subsidiary in the Cayman Islands. The facilities offer medical care in over 30 medical specialties and three of its hospitals – Narayana Institute of Cardiac Sciences, Bangalore, and Health City Cayman Islands – are JCI accredited. Wikipedia
About Narayana Hrudayalaya Ltd
CEOEmmanuel Rupert
Employees11.2K
Founded2000
HeadquartersBengaluru, Karnataka, India
SectorHealth care provider
Industry-
Websitenarayanahealth.org
Last report
Nov 2, 2026
Fiscal period
Q2 2027
₹14.82 / ₹13.50
+9.78%beat
Revenue / Est. (INR)
28.96B / 28.32B
+2.24%beat
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
21.51B
25.94B
26.84B
28.96B
Cost of goods sold
11.99B
18.24B
15.66B
16.27B
Cost of revenue
11.99B
18.24B
15.66B
16.27B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
2.56B
-
-
Operating expense
7.07B
4.14B
8.04B
8.26B
Total operating expenses
19.06B
22.38B
23.70B
24.53B
Operating income
2.45B
3.56B
3.14B
4.42B
Other non operating income
232.06M
-498.95M
354.76M
-
EBT including unusual items
1.50B
2.92B
2.60B
3.43B
EBT excluding unusual items
2.01B
2.80B
2.60B
3.43B
Income tax expense
222.70M
641.07M
531.19M
421.92M
Effective tax rate
14.81%
21.94%
20.40%
12.29%
Other operating expenses
5.85B
38.10M
6.48B
6.63B
Net income
1.27B
2.24B
2.07B
3.01B
Net profit margin
5.89%
8.63%
7.72%
10.40%
Earnings per share
8.45
11.22
10.20
14.82
Interest and investment income
-
594.31M
-
-
Interest expense
-650.33M
-912.85M
-868.01M
-967.19M
Net interest expenses
-650.33M
-318.54M
-868.01M
-967.19M
Depreciation and amortization charges
1.22B
1.54B
1.56B
1.63B
EBITDA
3.01B
4.45B
4.03B
6.02B
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps